BioSpace News Archive

Abbott (NYSE: ABT) today announced that the U.S. District Court for the Western District of Michigan has amended the recent consent decree allowing Abbott to release limited quantities of its EleCare® specialty amino acid-based formulas that were previously on hold following the Feb. 17 recall of some powder infant formulas from its Sturgis, Mich., facility.

Increasing awareness about early cancer diagnosis, rising prevalence of various types of cancers, and growing demand for precision medicine are some factors expected to drive global tumor genomics market growth.

Rising prevalence of sports injuries, chronic conditions, and spinal injuries worldwide, increasing overall healthcare expenditure, and technological advancements in electrotherapy systems are some key factors expected to drive global market growth

Rising prevalence of chronic disorders, increasing application of robotics in surgical procedures, and growing demand for minimally invasive surgeries are some key factors expected to drive global Robotics Surgical Simulation Systems market growth.

The latest market report presented by Reports and Data, titled “Intraocular Lens Market By Type (Monofocal, Multifocal, Toric, Accommodative), By Material (Polymethylmethacrylate (PMMA), Silicone, Hydrophobic Acrylic), By End-use (Hospitals, Ambulatory Surgical Centers, Ophthalmology Clinics, Eye Research Institutes), and By Region Forecast to 2028,” is inclusive of crucial data & information pertaining to the global Intraocular Lens market.

Reports and Data has published a novel report on global Phenylketonuria Market, By Product Type (Drugs, Nutrition Supplements, Others), By Type (Hyperphenylalaninemia, Mild PKU, Moderate & Variant, Classic PKU), By Application (Hospital Pharmacies, Online Pharmacies, Drug Stores, Pediatric Clinics, Others) and By Region Forecast to 2028 that offers a comprehensive overview of the market and helps investors, users understand market dynamics and make investment plans accordingly.

The U.S. Food and Drug Administration is providing an update on steps it has taken that will lead to millions of cans of additional infant and specialty formula being available to U.S. consumers.

Genexine a publicly traded, clinical stage biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of unmet medical needs, announced the appointment of Neil Warma as its President and Chief Executive Officer.

ERYTECH Pharma (Nasdaq& Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced the availability of the documents for its Annual General Meeting to be held on Friday, June 24, 2022.

Second Genome, presented data demonstrating the Company’s development candidate, SG-5-00455, improves epithelial barrier function and promotes mucosal healing by effectively inhibiting plasminogen activator inhibitor (PAI)-1/2 activity in the intestines.